Últimos Artículos de Cardiovascular Diabetology
- Urinary metabolomics provide insights into coronary artery disease in individuals with type 1 diabetes
- New insights into FGF21 alleviates diabetic cardiomyopathy by suppressing ferroptosis: a commentary
- Prognostic value of glycaemic variability for mortality in critically ill atrial fibrillation patients and mortality prediction model using machine learning
- The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better
- Combined impact of prediabetes and hepatic steatosis on cardiometabolic outcomes in young adults
- Pathways from insulin resistance to incident cardiovascular disease: a Bayesian network analysis
- SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)
- Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction
- Hemodialysis dose and frequency should be considered in subgroup analysis
- Different associations of atherogenic index of plasma, triglyceride glucose index, and hemoglobin A1C levels with the risk of coronary artery calcification progression according to established diabetes
- Expanded response letter to “Hemodialysis dose and frequency should be considered in the subgroup analysis”
- Intestinal fatty acid binding protein is associated with coronary artery disease in long-term type 1 diabetes—the Dialong study
- Assessing coronary artery stenosis exacerbated impact on left ventricular function and deformation in metabolic syndrome patients by 3.0 T cardiac magnetic resonance imaging
- The association between the stress hyperglycaemia ratio and mortality in cardiovascular disease: a meta-analysis and systematic review
- Machine learning for predicting in-hospital mortality in elderly patients with heart failure combined with hypertension: a multicenter retrospective study
- Lipophilic index of serum phospholipids in patients with type 2 diabetes and atherosclerotic cardiovascular disease: links with metabolic control, vascular inflammation and platelet activation
- Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives
- The mediatory role of androgens on sex differences in glucose homeostasis and incidence of type 2 diabetes: the KORA study
- Low-frequency variants in genes involved in glutamic acid metabolism and γ-glutamyl cycle and risk of coronary artery disease in type 2 diabetes
- Elevated glucose levels increase vascular calcification risk by disrupting extracellular pyrophosphate metabolism